Article
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
2 Mar 2010
Abstract excerpt
OBJECTIVE: To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage. DESIGN: Pooled analysis of two multicentre, phase three masked randomised controlled trials SETTING: Multicentre trials in several continents and in Costa Rica. PARTICIPANTS: 26 130 women aged 15-25 at enrolment; 3599 pregnancies eligible for analysis. INTERVENTIONS: Participants were randomly assigned...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
